REG - Deltex Med Grp PLC - Issue of Equity

Deltex MedicalAnnouncement

18/01/2024 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240118:nRSR2057Aa&default-theme=true

RNS Number : 2057A  Deltex Medical Group PLC  18 January 2024

18 January 2024

 

Deltex Medical Group plc

("Deltex Medical", the "Company" or the "Group")

 

Issue of equity to satisfy equity-settled non-executive directors' fees

 

The Board of Deltex Medical (AIM: DEMG), announces the issue of 49,372,352 new
ordinary shares of 1p each in the capital of the Company (the "Ordinary
Shares"), at an issue price of 0.17 pence per new Ordinary Share (the "Issue
Price"). The Issue Price represents the Company's closing mid-market price on
17 January 2024.

 

The new Ordinary Shares are being issued in order to satisfy the fees of
certain current and former non-executive directors for the year ending 31
December 2023 ("Fee Shares"), as has been done in previous years.

 

A total of 12,941,176 Fee Shares will be issued to former non-executive
director Mark Wippell and a total of36,431,176 Fee Shares will be issued to
current non-executive directors as set out below:

 

                                                               Resultant holding post Fee Shares
 Director     Current Ordinary Shares held  Fee Shares issued  Ordinary Shares held  As a percentage of the enlarged share capital on Admission
 Nigel Keen   332,267,649                   22,313,529         354,581,178           18.70%
 Chris Jones  6,479,109                     14,117,647         20,596,756            1.09%

 

Under the contract with Nigel Keen, he or the Company can opt to settle his
fees (plus employer's national insurance) by the issue of new ordinary shares
at the share price at the time of issue and the same applies to Chris Jones'
and Ben Carswell's contracts for up to half of their fees. These share issues
are expected to occur on an annual basis when permitted.

 

Application for admission to trading and total voting rights

 

Application has been made for 49,372,352 new Ordinary Shares to be admitted to
trading on AIM, which is expected to take effect on or around 24 January 2024
("Admission").

 

Following Admission, the Company's issued share capital will comprise
1,896,025,700 Ordinary Shares. The Company does not hold any Ordinary Shares
in treasury. This figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

 Deltex Medical Group plc                                        01243 774 837
 Nigel Keen, Chairman                                             investorinfo@Deltexmedical.com (mailto:investorinfo@Fitbitmedical.com)
 Andy Mears, Chief Executive
 Natalie Wettler, Group Finance Director

 Nominated Adviser and Broker                                    020 3328 5656

 Allenby Capital Limited
 Jeremy Porter / Vivek Bhardwaj (Corporate Finance)              info@allenbycapital.com (mailto:info@allenbycapital.com)
 Tony Quirke / Stefano Aquilino (Sales & Corporate Broking)

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them:

 

 1.    Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         PDMRs:

Nigel Keen   Non-Executive Director - Chairman
                                                                    Chris Jones  Non-Executive Director

 

 2.    Reason for the Notification
 a)    Position/status                                              See 1a) above
 b)    Initial notification/Amendment                               Initial Notification
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Deltex Medical Group Plc
 b)    LEI                                                          213800XN34P6LI8J6M39
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the Financial instrument, type of instrument  Ordinary shares of 0.1p each in Deltex Medical Group Plc

       Identification code                                          ISIN: GB0059337583
 b)    Nature of the transaction                                    Fee shares
 c)    Price(s) and volume(s)                                       Name         Price(s)  Volume(s)
                                                                    Nigel Keen   0.17p     22,313,529
                                                                    Chris Jones  0.17p     14,117,647
 d)    Aggregated information:
       -  Aggregated volume                                         36,431,176
       -  Price                                                     0.17p
 e)    Date of the transaction                                      18 January 2024
 f)    Place of the transaction                                     Outside a trading venue

 

 

2.

Reason for the Notification

a)

Position/status

See 1a) above

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)

Name

Deltex Medical Group Plc

b)

LEI

213800XN34P6LI8J6M39

4.

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each in Deltex Medical Group Plc

 

Identification code

ISIN: GB0059337583

b)

Nature of the transaction

Fee shares

c)

Price(s) and volume(s)

 Name         Price(s)  Volume(s)
 Nigel Keen   0.17p     22,313,529
 Chris Jones  0.17p     14,117,647

d)

Aggregated information:

-  Aggregated volume

36,431,176

-  Price

0.17p

e)

Date of the transaction

18 January 2024

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOESFUFMAELSEIF